56
8
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7802 |
M1001
|
HIF/HIF Prolyl-Hydroxylase; HIF | Angiogenesis; Chromatin/Epigenetic; Metabolism |
M1001 是较弱的HIF-2α激动剂,直接与 HIF-2α PAS-B 结构域结合,Kd=667 nM,能够提高 HIF-2α-ARNT 复合体之间的稳定性。 | |||
T9022 |
AZD9977
AZD 9977 |
Glucocorticoid Receptor | Endocrinology/Hormones |
AZD9977 是一种选择性的,有效的,具有口服活性的盐皮质激素受体 (MR) 调节剂,可用于研究心力衰竭和慢性肾病。 | |||
T8528 |
AC1903
|
TRP/TRPV Channel | Membrane transporter/Ion channel |
AC1903是一种选择性的TRPC5抑制剂,具有足细胞保护特性,对 TRPC4 或 TRPC6没有影响,并且在激酶谱分析中没有显示出脱靶效应。在局灶节段性肾小球硬化大鼠模型中,AC1903抑制严重蛋白尿,并且防止足细胞丢失。 | |||
T11394 |
GFB-8438
|
TRP/TRPV Channel | Membrane transporter/Ion channel |
GFB-8438 是有效的TRPC5选择性抑制剂,对 hTRPC5 和 hTRPC4 的IC50分别为 0.18 和 0.29 μM。它对 TRPC6、其他 TRP 家族成员、NaV1.5 具有良好的选择性,对 hERG 通道的活性也有限。它对小鼠足细胞的保护作用。 | |||
T1874 |
PPQ-102
PPQ102,CFTR Inhibitor,PPQ 102 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
PPQ-102 (CFTR Inhibitor) 是一种CFTR 抑制剂,可以完全抑制CFTR 氯化物电流,IC50为90 nM。 | |||
T4583 |
PFI-2 hydrochloride
(R)-PFI-2 hydrochloride,PFI-2 HCl |
Histone Methyltransferase | Chromatin/Epigenetic |
PFI-2 hydrochloride ((R)-PFI-2 hydrochloride) 是一种有效的、高度选择性的、具有细胞活性的 SETD7 甲基转移酶抑制剂,IC50值为2nM,活性是 (S)-PFI-2 的 500 倍。 | |||
T1615 |
Irbesartan
厄贝沙坦,SR-47436,BMS-186295 |
Apoptosis; RAAS | Apoptosis; Endocrinology/Hormones |
Irbesartan (SR-47436) 是一种 1 型血管紧张素 II 受体拮抗剂,IC50为1.3 nM。 | |||
T4651 |
Vadadustat
N-(5-(3-氯苯基)-3-羟基吡啶-2-羰基)甘氨酸,PG-1016548,AKB-6548 |
HIF/HIF Prolyl-Hydroxylase; HIF | Angiogenesis; Chromatin/Epigenetic; Metabolism |
Vadadustat 是一种可滴定口服的缺氧诱导因子脯氨酰羟化酶 (HIF-PH) 抑制剂,是一种促红细胞生成剂,在动物慢性肾脏疾病模型中,有用于贫血的研究潜力。 | |||
T21395 |
Finerenone
BAY948862,BAY-948862,BAY94-8862,非奈利酮,BAY 94-8862,BAY-94-8862,BAY 948862 |
Glucocorticoid Receptor | Endocrinology/Hormones |
Finerenone (BAY-948862) 是一种选择性、具有口服活性的、非甾体类盐皮质激素受体拮抗剂 (IC50=18 nM)。与糖皮质激素受体、雄激素受体和孕酮受体相比,它表现出良好的选择性 (>500-fold)。它在心肾疾病研究中具有潜在的应用前景,如 2 型糖尿病和慢性肾脏疾病。 | |||
T6666 |
Sevelamer Carbonate
|
Others | Others |
Sevelamer carbonate 是一种口服具有活力的非钙基磷酸盐结合剂,能有效降低体内血清磷水平,但对体内血清钙、氯水平影响极小,可用于研究慢性肾脏病的高磷血症。它被认为是七氟乙烯的一种改进的缓冲形式。 | |||
T1987 |
PFI-2
PFI2,PFI 2,(R)-PFI-2 |
Histone Methyltransferase | Chromatin/Epigenetic |
PFI-2 是一种有效、特异性和细胞活性的赖氨酸甲基转移酶 SETD7 抑制剂,Ki 和 IC50值分别为 0.33 和 2 nM。 | |||
T40108 |
Inaxaplin
VX-147 |
Others | Others |
Inaxaplin 是一种载脂蛋白L1(APOL1)功能抑制剂。Inaxaplin 可用于肾脏疾病的研究。 | |||
T13591 |
Calcium polystyrene sulfonate
Poly(styrenesulfonic acid) calcium salt,聚苯乙烯磺酸钙 |
Others | Others |
Calcium polystyrene sulfonate (Poly(styrenesulfonic acid) calcium salt) 是一种离子交换树脂。 Calcium polystyrene sulfonate 可降低血钾水平,可用于治疗慢性肾病患者高钾血症的研究。 | |||
T0080 |
Trapidil
唑嘧胺,乐可安,Rocornal,Trapymine,Avantrin,Trapymin,AR-12008 |
PDGFR; PDE | Angiogenesis; Metabolism; Tyrosine Kinase/Adaptors |
Trapidil (Avantrin) 是一种抗血小板药物,是一种血管扩张剂,有特异性血小板衍生生长因子。 | |||
T77364 |
Sibeprenlimab
VIS649,VIS-649 |
Others | Others |
Sibeprenlimab (VIS649) 是一种抑制 APRIL 的人源化IgG 2单克隆抗体。Sibeprenlimab 对 APRIL 有抑制作用,可用于研究预防和治疗 肾病(IgAN)。 | |||
T60170 |
BLU2864
|
Others | Others |
BLU2864 是一种具有口服活性的、高选择性的、ATP 竞争性的 PRKACA 抑制剂 ,IC50值为0.3 nM。BLU2864 具有抗肿瘤活性,具有用于癌症和多囊肾的研究潜力。 | |||
T50000 |
2-Iodohippuric Acid
|
Others | Others |
2-Iodohippuric Acid 可以用来测量肾脏的清除率用于肾功能研究,也用于某些疾病的诊断,如肝病和肾病。此外,它还用于某些药物的合成。 | |||
T40109 |
APOL1-IN-1
APOL1-IN-1 |
Others | Others |
APOL1-IN-1是一种有效的载脂蛋白 L1(APOL1) 的抑制剂,可用于研究局灶节段性肾小球硬化 (FSGS) 和非糖尿病肾病 (NDKD) 的发病原理,促进对此类疾病的研究。 | |||
T30479 |
Bis-T-23
Bis T-23,Bis-T 23,AG1717 |
HIV Protease | Microbiology/Virology; Proteases/Proteasome |
Bis-T-23是一种肌动蛋白依赖性达纳敏低聚物的促进剂,是一种 HIV-I 整合酶抑制剂,是泰尔普斯丁衍生物。Bis-T-23可以促进肌动蛋白依赖性的dynamin 寡聚化。Bis-T-23可用于HIV 和慢性肾脏疾病(CKD)的研究。 | |||
T13604 |
CDDO-dhTFEA
|
Others; NF-κB; Nrf2 | Immunology/Inflammation; NF-κB; Others |
CDDO-dhTFEA 是合成的齐墩果烷三萜化合物,可有效激活Nrf2并抑制促炎转录因子NF-κB。 它可以恢复高血压 (MAP),提高 Nrf2 及其靶基因的表达,抑制 NF-κB 的活化和转化生长因子-β 途径,并减少慢性肾病 (CKD) 大鼠的肾小球硬化,间质纤维化和炎症。 | |||
T28222 |
5-Hydroxy-1-methylhydantoin
HD-003,HD003,5-羟基-1-甲基咪唑啉-2,4-二酮,NZ419,NZ-419,HD 003,NZ 419 |
Bradykinin Receptor | GPCR/G Protein |
5-Hydroxy-1-methylhydantoin (HD-003) 是一种可能用于治疗肾衰竭的抗氧化剂。它是肌酐代谢物,是一种羟基自由基清除剂,此前已显示通过抑制大鼠慢性肾病的进展来提供肾脏保护。 它是一种新型抗氧化药物,可完全抑制 B2-激肽受体(B2KR) 对 VSMC 中高葡萄糖 (25 mM) 刺激的反应,并且还显示可减弱 BK 对 VSMC 重塑的影响。它抑制 BK 诱导的 MAPK 磷酸化增加并减弱 VSMC 中结缔组织生长因子 (CTGF) 蛋白水平的增加。这些研究结果表明,它可能通过其抗氧化特性赋予血管保护免受高葡萄糖浓度和 BK 刺激以改善血管损伤和重塑。 | |||
T38768 |
Ocedurenone
|
||
Ocedurenone, a corticosteroid receptor antagonist, is a compound utilized in the investigation of kidney disease (WO2018054357, compound I). | |||
T34107 |
Polythiazide
P2525,NSC-108161,NSC 108161,P-2525,NSC108161 |
||
Polythiazide (NSC-108161, P-2525) is used to treat fluid retention (edema) caused by a variety of causes, including congestive heart failure, severe liver disease (cirrhosis), kidney disease, or steroid or hormonal medication. | |||
T32193 |
Iron sorbitex
Jectofer,Yectofer,Iron Sorbitol,HSDB 1967,Astra 1572 |
||
Iron Sorbitex is used for the treatment of Iron Sorbitex deficiency anemia in patients with chronic kidney disease. Iron Sorbitex can be used as an Iron Sorbitex replacement product used for the treatment of Iron Sorbitex deficiency anemia in patients wit | |||
T39105 |
Ibiglustat succinate
GZ402671succinate,Venglustat succinate,Ibiglustat succinate,SAR402671succinate |
||
Ibiglustat (Venglustat) succinate is an orally active, brain-penetrant inhibitor of glucosylceramide synthase (GCS). It is utilized in the investigation of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease. | |||
T1605L |
Enalapril sodium
(-)-Enalapril sodium |
||
Enalapril sodium is used to treat high blood pressure, diabetic kidney disease, and heart failure and can be generally used with a diuretic such as furosemide for heart failure. | |||
T39410 |
Zevaquenabant
(S)-MRI-1867 |
||
Zevaquenabant ((S)-MRI-1867), a dual cannabinoid CB1 receptor and inducible NOS (iNOS) antagonist, is orally bioavailable and peripherally restricted. It effectively mitigates obesity-induced chronic kidney disease (CKD). | |||
T60937 | TRPC5-IN-1 | ||
TRPC5-IN-1是一种TRPC5抑制剂,在各种慢性肾病动物模型中均具有活性。 | |||
T73332 |
BI-685509
|
||
BI-685509 是一种口服有效的sGC 激活剂。BI-685509 可恢复环磷酸鸟苷 (cGMP) 并改善一氧化氮 (NO) 通路的功能。BI-685509 可用于慢性肾病 (CKD) 和糖尿病肾病 (DKD) 的研究。 | |||
T38419 |
Difelikefalin
CR-845,FE-202845 |
||
Difelikefalin (CR-845; FE-202845) is a peripherally restricted, selective agonist of the kappa opioid receptor (KOR). It exhibits anti-inflammatory properties and holds promise for modulating pruritus in conditions associated with chronic kidney disease. | |||
T20118 |
L-Penicillamine
|
||
L-Penicillamine is a medication primarily. It is used for the treatment of Wilson's disease. It is also used for people with kidney stones who have high urine cystine levels, rheumatoid arthritis, copper poisoning, and lead poisoning. | |||
T64174 |
Vasopressin V2 receptor antagonist 1
|
||
Vasopressin V2 receptor antagonist 1 (Compound 4g) 是一种 vasopressin V2receptor (V2R) 拮抗剂 (Ki: 3.8 nM)。Vasopressin V2 receptor antagonist 1 可以用于研究常染色体显性多囊肾病 (ADPKD)。 | |||
T39712 |
RGLS4326
RG4326,RGLS4326 |
||
RGLS4326 (RG4326) is a short oligonucleotide inhibitor of microRNA-17 (miR-17), with a pioneering role in its class. This compound, with a research focus on autosomal dominant polycystic kidney disease (ADPKD), effectively suppresses the activity of miR-17 in HeLa cells, displaying an EC50 value of 28.3 nM. | |||
T62589 |
TRPC5-IN-4
|
||
TRPC5-IN-4 是一种有效且安全的TRPC 抑制剂,对TRPC5和TRPC4的IC50分别为 14.07 nM 和 65 nM。TRPC5-IN-4 对肝、肾细胞成分无损伤。TRPC5-IN-4 可用于慢性肾脏病的研究 (CKD)。 | |||
T80220 |
OK2
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
OK2为CCN2/EGFR交互作用的特异性抑制剂,其通过结合CCN2的CT结构域,有效阻断了CCN2/EGFR的交互作用。该化合物适用于肾纤维化与慢性肾脏疾病研究。 | |||
T61362 |
CDK5-IN-3
|
||
CDK5-IN-3 (compound 11) is a highly potent and selective inhibitor of CDK5, demonstrating significant inhibition with IC50 values of 0.6 nM and 18 nM for CDK5/p25 and CDK2/CycA, respectively. This compound holds promise for further investigation in the context of autosomal dominant polycystic kidney disease (ADPKD) research [1]. | |||
T77074 | Lulizumab pegol | ||
Lulizumab pegol (BMS-931699) 为一种抗CD28抗体拮抗剂,能有效抑制T细胞增殖。其主要应用于肾移植和自身免疫性疾病的研究。 | |||
T69294 | UK‑396082 | ||
UK-396082为一有效的TAFI抑制剂,能增进纤溶酶活性并促使ECM水平下降,适用于CKD研究。 | |||
T63293 |
Axl-IN-7
|
||
Axl-IN-7 是 AXL 的有效抑制剂。Axl-IN-7 能够用于研究 Axl 相关疾病,如癌症(如急性髓系白血病、乳腺癌、黑色素瘤、胰腺癌和神经胶质肿瘤)、免疫系统紊乱、肾脏疾病和心血管疾病。 | |||
T74097 | THX-B | ||
THX-B为一高效非多肽类p75NTR(神经营养蛋白受体p75)拮抗剂,适用于糖尿病、肾病、神经退行性及炎症性疾病研究。 | |||
T76947 | Ziltivekimab | ||
Ziltivekimab (COR-001) 是一种人源化抗IL-6单克隆抗体,具有降低血清CRP的效能,并展现出抗炎活性。该化合物在CKD相关的慢性全身性炎症及心血管疾病研究中有潜在应用。 | |||
T83872 |
Oleoyl-L-carnitine chloride
L-Carnitine oleoyl ester,L-Octadecanoylcarnitine,C18:1 Carnitine,CAR 18:1 |
||
Oleoyl-L-carnitine是一种长链酰基肉碱,也是一种糖苷转运体2(GlyT2;IC50 = 340 nM)的抑制剂,对GlyT2比对GlyT1(IC50 = >10,000 nM)具有选择性。慢性肾脏病或接受初始血液透析的终末期肾脏病患者的血浆中Oleoyl-L-carnitine水平增高,这与心血管死亡率相关。 | |||
T78513 |
Sodium zirconium cyclosilicate
|
Others | Others |
Sodium zirconium cyclosilicate 是一种新型口服、不吸收的无机微孔硅酸盐锆化合物,高选择性地作为阳离子交换剂,专门用于去除体内过量的K+。该化合物适用于慢性肾脏疾病(CKD)的研究。 | |||
T69035 | Camostat free base | ||
Camostat, also known as FOY 305, is a serine protease inhibitor. Camostat is used in the treatment of some forms of cancer and is also effective against some viral infections, as well as inhibiting fibrosis in liver or kidney disease or pancreatitis. It is an inhibitor of the enzyme transmembrane protease, serine 2 (TMPRSS2). Inhibition of TMPRSS2 partially blocked infection by SARS-CoV and Human coronavirus NL63 in HeLa cell cultures. In vitro study showed that camostat significantly reduces... | |||
T60909 | SSAO inhibitor-3 | ||
SSAO inhibitor-3 (Compound 2) 可用于研究动脉粥样硬化、糖尿病及其并发症、肥胖症、中风、慢性肾病、视网膜病变、慢性阻塞性肺病 (COPD)、自身免疫性疾病、多发性硬化等。SSAO inhibitor-3 是一种氨基脲敏感性胺氧化酶 (SSAO) 的抑制剂,对人 AOC1 和SSAO 的IC50分别为 0.1-10 μM 和 <10 nM 。 | |||
T37439 |
C18 Globotriaosylceramide (d18:1/18:0)
|
||
C18 globotriaosylceramide is an endogenous sphingolipid found in mammalian cell membranes that is synthesized from lactosylceramide . It inhibits aggregation of human neutrophils induced by phorbol 12-myristate 13-acetate (PMA; 10008014) when used at a concentration of 1 μM. C18 globotriaosylceramide acts as a receptor for Shiga toxin in B cell-derived Raji cells and THP-1 monocytes. It accumulates in the brain, heart, kidney, liver, lung, and spleen in a mouse model of Fabry disease, a lysosoma... | |||
T36384 |
DL-Tyrosine-13C9,15N
L-Tyrosine-13C9,15N |
||
L-Tyrosine-13C9,15N is intended for use as an internal standard for the quantification of L-tyrosine by GC- or LC-MS. L-Tyrosine is a non-essential amino acid.1It is produced by hydroxylation of phenylalanine by phenylalanine hydroxylase but can also be obtained from dietary sources or degradation of endogenous proteins, resulting in L-tyrosine release.1,2L-Tyrosine is a precursor in the biosynthesis of catecholamine neurotransmitters, melanins, and thyroid hormones.3Plasma, skeletal muscle, and... | |||
T60640 |
SSAO inhibitor-2
|
||
SSAO inhibitor-2 (Compound 1) 可用于动脉粥样硬化、糖尿病及其并发症、肥胖、中风、慢性肾病、视网膜病变、慢性阻塞性肺病 (COPD)、自身免疫性疾病、多发性硬化等的研究。SSAO inhibitor-2 是氨基脲敏感性胺氧化酶 (SSAO) 抑制剂,其对人 SSAO 和 MAO-A 的IC50分别为 <10 nM 和 10-100 μM。 | |||
T35881 |
Resolvin E2
|
||
Resolvin E2 (RvE2) is a member of the specialized pro-resolving mediator (SPM) family of bioactive lipids.1It is produced from eicosapentaenoic acidviaan 18-HEPE intermediate, which is formed by aspirin-acetylated COX-2-mediated oxidation of EPA, by 5-lipoxygenase (5-LO) in human polymorphonuclear (PMN) neutrophils.2,3RvE2 (20 ng/animal) inhibits increases in inflammatory exudate neutrophil infiltration in a mouse model of peritonitis induced by zymosan A .3Hepatic RvE2 levels are increased in m... | |||
T73163 | CDK7-IN-20 | ||
CDK7-IN-20 是一种有效的、选择性的、不可逆的 CDK7(CDK) 抑制剂,IC50值为 4 nM。CDK7-IN-20 对 CDK7的选择性超过 CDK1、CDK2、CDK3、CDK5、CDK6、CDK9 和 CDK12的 206 倍以上。CDK7-IN-20 具有用于常染色体显性多囊肾病 (ADPKD) 研究的潜力。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2S1837 |
Steviol
甜菊醇,NSC 226902,Hydroxydehydrostevic acid |
Others | Others |
Steviol (NSC-226902) 是一种甜菊糖甙的主要代谢物。它能降低 AQP2 的表达,并促进 AQP2 的降解,从而减缓肾囊肿的生长。 | |||
T14002 |
12-Ketodeoxycholic acid
|
Endogenous Metabolite | Metabolism |
12-Ketodeoxycholic acid 是一种胆汁酸,由肾脏代谢产生。它是肾脏损伤的标志物。 | |||
T21977 |
p-Cresyl sulfate
|
Others | Others |
p-Cresyl Sulfate 是主要的尿毒症毒素,存在于慢性肾病患者的血液,来源于肝脏中酪氨酸和苯丙氨酸的代谢物。 | |||
T5623 |
Bisphenol A
|
Others; Endogenous Metabolite | Metabolism; Others |
Bisphenol A 是酚类内源性代谢合成物,广泛用于环氧树脂和聚碳酸酯塑料的生产。它是生殖、发育和全身毒性物质,常被归类为内分泌干扰物。它与许多疾病有关,包括呼吸系统疾病、心血管疾病、糖尿病、肾脏疾病、肥胖和生殖障碍。 | |||
T4938 |
Potassium 1H-indol-3-yl sulfate
硫酸吲哚钾盐,Indoxyl sulfate potassium salt,Potassium 3-indoxyl sulfate |
AhR; Endogenous Metabolite | Immunology/Inflammation; Metabolism |
Potassium 1H-indol-3-yl sulfate (Potassium 3-indoxyl sulfate) 是人芳烃受体(AhR)的激动剂。芳烃受体(AhR)最近被发现是免疫炎症条件的病理生理调节剂,Potassium 1H-indol-3-yl sulfate 已被证明是AhR的配体。Potassium 1H-indol-3-yl sulfate 也是膳食蛋白质中色氨酸的代谢物。色氨酸被肠道细菌代谢为吲哚,吲哚被吸收到血液中,然后在肝脏中进一步代谢为硫酸吲哚,通常通过尿液排出体外。在肾功能受损的慢性肾病患者中,Potassium 1H-indol-3-yl sulfate 可作为尿毒症毒素在血清中积累,诱导氧化应激并加速疾病进展。250 μM Potassium 1H-indol-3-yl sulfate 可诱导NF-Κb活化,促进大鼠近端小管细胞TGF-β1和Smad3的表达,与促纤维化活性相关。 | |||
T8274 |
3-Methyl-L-histidine
|
Endogenous Metabolite | Metabolism |
3-Methyl-L-histidine 是一种肉类尤其是鸡肉摄入和大豆制品摄入的生物标记。 | |||
T77988 |
Phenyl sulfate
Phenyl hydrogen sulfate |
Endogenous Metabolite | Metabolism |
Phenyl sulfate为肠道微生物衍生的口服活性代谢物,能在糖尿病实验模型中诱发蛋白尿及足细胞损伤,其可能成为糖尿病肾病的疾病标志物和未来治疗靶点。 | |||
T37291 |
Lyso-Globotriaosylceramide (d18:1)
Lyso-Globotriaosylceramide (d18:1) |
||
Lyso-globotriaosylceramide is a form of globotriaosylceramide that is lacking the fatty acyl group. It binds to Shiga toxin 1 (Stx1) in the presence of cholesterol and phosphatidylcholine but does not bind Stx2. It also reduces viability and aggregation of human neutrophils induced by phorbol 12-myristate 13-acetate when used at concentrations of 50 and 1 μM, respectively. Lyso-globotriaosylceramide accumulates in the brain, heart, kidney, liver, lung, and spleen in a mouse model of Fabry diseas... |